Overevoeligheidsreactie bij chemotherapie: Succesvolle 'rechallenge' met cromoglicaat

Translated title of the contribution: Successful rechallenge with cromoglycate prophylaxis. Hypersensitivity reaction in chemotherapy

M. E. De Jonge, A. D.R. Huitema, J. H. Beijnen, J. H.M. Schellens, S. Rodenhuis

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Hypersensitivity reactions (HSRs) are not uncommon in chemotherapy. In some situations antihistaminics and corticosteroids may be used in the prevention of HSRs. In this case report, a breast cancer patient with a severe HSR on high dose cyclophosphamide, thiotepa and carboplatin (tCTC) is described, who was able to continue tCTC therapy successfully after use of prophylactic oral cromoglycate. It was concluded that cromoglycate may be useful in the prophylaxis of chemotherapy-induced HSRs and should be further studied in this setting.

Translated title of the contributionSuccessful rechallenge with cromoglycate prophylaxis. Hypersensitivity reaction in chemotherapy
Original languageDutch
Pages (from-to)874-878
Number of pages5
JournalPharmaceutisch Weekblad
Volume138
Issue number25
Publication statusPublished - 20 Jun 2003
Externally publishedYes

Fingerprint

Dive into the research topics of 'Successful rechallenge with cromoglycate prophylaxis. Hypersensitivity reaction in chemotherapy: Succesvolle 'rechallenge' met cromoglicaat'. Together they form a unique fingerprint.

Cite this